Child & Adolescent Component
National Survey of Mental Health &
Well-being
| This was
a report based on a national survey involving 4,500 children conducted
by staff of the University of Adelaide. The Child and Adolescent Component
of the National Survey of Mental Health and Well-being showed that 14
per cent of children and adolescents (more than half a million in a total
Australian population of nineteen million people) have some form of behavioural
problem. About 15 per cent seemed to have symptoms of three specific mental
disorders assessed in the survey: attention deficit/hyperactivity disorder,
depressive disorder and conduct disorder.
ADHD was the most prevalent, affecting 11.2 per cent of children. Young boys were at most risk, with almost 20 per cent of those aged 6-12 affected. The most prevalent problems reported by parents in their children were anxiety disorders and delinquent behaviour, including persistent lying, swearing, stealing and truancy. Adolescents themselves were much more likely to report depressive disorders and feelings of alienation, loneliness and worthlessness. Up to 12% of adolescents reported anti-social or under-controlled behaviour and one-fifth reported anxiety and depression. A staggering 12 per cent of adolescents had had thoughts about suicide in the previous twelve months; that figure rose to 42 per cent among teenagers with high-level problems. It is likely that serious rates of mental illness exist in the populations of others of the world's more prosperous countries, which implies that world wide untold millions of children are severely affected. In such a crisis situation a carefully elaborated, scientifically argued hypothesis such as Hafer's, which offers both a causative explanation and an inexpensive, practical solution, and which is supported as effective by families which have tried it over a twenty year period, deserves very serious investigation by responsible professionals and government agencies. Reference: "The Australian" Newspaper, November 30 2000, p 6 |
|
Return
to Supportive Evidence Summary page
|
| PhosADD Australia | email: mail@phosadd.com |
![]() |
| ABN: 64021647394 | www.phosadd.com |